Shadab Abadpour

Shadab Abadpour is a Postdoctoral Research Fellow at the University of Oslo, affiliated with the Institute for Molecular Biosciences (IMB) and the Hybrid Technology Hub. He is part of The Scholz Group, focusing on advancing bioengineering and regenerative medicine approaches for pancreatic islet research and diabetes treatment. His work integrates stem cell biology, organ-on-a-chip technologies, and proteomics to study islet function, transplantation outcomes, and metabolic interactions.

Research interests include stem cell differentiation, bioengineered transplantation platforms, and metabolic crosstalk modeling. He collaborates extensively with teams in molecular biology, analytical chemistry, and clinical research, contributing to projects like improving islet preservation in 3D bioprinted scaffolds and developing organ-on-a-chip systems for disease modeling.

Abadpour has published widely in journals such as Frontiers in Bioengineering and Biotechnology, Advanced Healthcare Materials, and Diabetologia. His recent studies explore age-dependent islet dynamics, glucose regulation in stem cell differentiation, and proteomic markers of islet homeostasis. He also investigates the role of prostaglandin signaling and adipose-derived stromal cells in enhancing islet survival post-transplantation.

Key contributions include the development of a pump-less organ-on-chip platform to model islet-liver interactions and the use of LC-MS techniques for analyzing insulin secretion from stem cell-derived islet organoids. His work bridges fundamental research and translational applications in diabetes therapy.